TICKERNOMICS Sign up
Last Update: 2023-12-23 05:57:52
BAXTER INTERNATIONAL INC ( BAX ) https://www.baxter.com
38.91USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-20.13%
BAX
SPY
30.72%
-46.16%
BAX
SPY
112.82%
-27.86%
BAX
SPY
201.04%
BAX
39.87%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
19805.19
33372.19
5.05
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
7.64
1.32
2.43
4.34
2.98
30.15
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-1.38
30.12
7.40
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.3854
2.22
-0.95
0.61
Other Earnings and Cash Flow Stats:
BAXTER INTERNATIONAL INC ( BAX ) Net Income TTM ($MM) is -201.00
BAXTER INTERNATIONAL INC ( BAX ) Operating Income TTM ($MM) is -218.00
BAXTER INTERNATIONAL INC ( BAX ) Owners' Earnings Annual ($MM) is 2972.07
BAXTER INTERNATIONAL INC ( BAX ) Current Price to Owners' Earnings ratio is 8.64
BAXTER INTERNATIONAL INC ( BAX ) EBITDA TTM ($MM) is 1080.00
BAXTER INTERNATIONAL INC ( BAX ) EBITDA Margin is 7.40%
Capital Allocation:
BAXTER INTERNATIONAL INC ( BAX ) has paid 1.16 dividends per share and bought back -5.0 million shares in the past 12 months
BAXTER INTERNATIONAL INC ( BAX ) has increased its debt by 2190.0 million USD in the last 12 months
Capital Structure:
BAXTER INTERNATIONAL INC ( BAX ) Interest-bearing Debt ($MM) as of last quarter is 19355
BAXTER INTERNATIONAL INC ( BAX ) Annual Working Capital Investments ($MM) are -4598
BAXTER INTERNATIONAL INC ( BAX ) Book Value ($MM) as of last quarter is 8166
BAXTER INTERNATIONAL INC ( BAX ) Debt/Capital as of last quarter is 238%
Other Balance Sheet Stats:
BAXTER INTERNATIONAL INC ( BAX ) has 5788 million in cash on hand as of last quarter
BAXTER INTERNATIONAL INC ( BAX ) has 6209 million of liabilities due within 12 months, and long term debt 16493 as of last quarter
BAXTER INTERNATIONAL INC ( BAX ) has 509 common shares outstanding as of last quarter
BAXTER INTERNATIONAL INC ( BAX ) has 0 million USD of preferred stock value
Academic Scores:
BAXTER INTERNATIONAL INC ( BAX ) Altman Z-Score is 1.96 as of last quarter
BAXTER INTERNATIONAL INC ( BAX ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
BAXTER INTERNATIONAL INC ( BAX ) largest shareholder is Ameriprise Financial Inc owning 9737776 shares at 378.90 ($MM) value
Albert P L Stroucken(an insider) Sold 3930 shares of BAXTER INTERNATIONAL INC ( BAX ) for the amount of $147453.60 on 2023-03-20
0.27% of BAXTER INTERNATIONAL INC ( BAX ) is held by insiders, and 89.08% is held by institutions
BAXTER INTERNATIONAL INC ( BAX ) went public on 1981-10-27
Other BAXTER INTERNATIONAL INC ( BAX ) financial metrics:
FCF:887.00
Unlevered Free Cash Flow:-854.00
EPS:19.71
Operating Margin:-1.38
Gross Profit Margin:30.12
Div. Payout Ratio%:22.78
Div. Growth YoY%:1.75
Equity Return%:123.84
Beta:0.61
Buffet's Owners Earnings:2972.07
Price to Owner's Earnings:8.64
About BAXTER INTERNATIONAL INC ( BAX ) :
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.